Skip to content

Clinical trials

Kidney Neoplasms trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Country / region: Czechia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20091
20121
20151
20172
20201
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Arcus Biosciences, Inc.1
Argos Therapeutics1
Bristol-Myers Squibb1
Charles University, Czech Republic1
Gustave Roussy, Cancer Campus, Grand Paris1
Merck Sharp & Dohme LLC1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms14
Carcinoma, Renal Cell10
Kidney Diseases1
Recurrence1
Renal Insufficiency1
Urogenital Neoplasms1
Urologic Diseases1
Wilms Tumor1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.